STREAMING NOW: Watch Now

FDA approves new osteoporosis drug for postmenopausal women

The US Food and Drug Administration has approved a new treatment for osteoporosis in postmenopausal women who are at high risk of bone fractures.The F...

Posted: Apr 10, 2019 3:29 AM

The US Food and Drug Administration has approved a new treatment for osteoporosis in postmenopausal women who are at high risk of bone fractures.

The FDA announced Tuesday that the drug, called romosozumab, which has the brand name Evenity, works mainly by boosting bone formation and is approved to treat osteoporosis in women with a history of osteoporotic fracture or multiple risk factors for fracture, or those who have not benefited from other types of osteoporosis therapies.

"Today's approval provides women with postmenopausal osteoporosis who are at high risk of fracture with a new treatment that will reduce this risk," Dr. Hylton V. Joffe, director of the FDA Center for Drug Evaluation and Research's Division of Bone, Reproductive and Urologic Products, said in the announcement.

"But Evenity may increase the risk of heart attack, stroke and cardiovascular death so it's important to carefully select patients for this therapy, which includes avoiding use in patients who have had a heart attack or stroke within the previous year," he said.

The drug was developed by the pharmaceutical companies Amgen and UCB, which worked together on development since 2004.

It is expected to be available from select wholesalers in the United States for physicians to order in about a week, at which time the price will be made publicly available, Amgen spokeswoman Kristen Davis wrote in an email Tuesday.

The FDA noted that one dose of Evenity is administered as two back-to-back injections given once a month by a health care professional. No more than 12 doses should be used, so if treatment is still needed after 12 months, other types are encouraged.

"The FDA approval of Evenity represents an important therapeutic development for patients who need a medicine that can rapidly increase bone mineral density and help reduce the risk of future fractures within 12 months," Dr. David M. Reese, executive vice president of research and development at Amgen, said in a news release Tuesday.

"Postmenopausal osteoporosis is a significant women's health issue that far too often gets overlooked. As a leader in bone health with more than 20 years of osteoporosis research experience, Amgen is as committed as ever to combatting this disease to help women at high risk for fracture reduce their risk of a first and subsequent fracture," he said.

The safety and efficacy of Evenity were tested in two clinical trials involving more than 11,000 women with postmenopausal osteoporosis, according to the FDA.

Although the trials found the drug to be effective in lowering the risk of a new fracture, the agency noted that there were some side effects, including an increased risk of cardiovascular death, heart attack and stroke.

The drug packaging comes with a "boxed warning" stating those risks and that the treatment should not be used in patients who have had a heart attack or stroke within the previous year. Other side effects of Evenity include joint pain and headache, and possible reactions or discomfort at the injection sites.

Osteoporosis is a disease that involves low bone mass and deterioration of bone tissue, leading to an increased risk of bone fractures, such as those of the hip, spine and wrist. Of the estimated 10 million people in the United States with osteoporosis, more than 80% are thought to be women.

Oregon Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 9930

Reported Deaths: 213
CountyConfirmedDeaths
Multnomah241769
Marion161047
Washington153420
Clackamas82125
Umatilla7166
Union3551
Lincoln3463
Deschutes2110
Lane2083
Malheur1911
Polk15912
Linn1579
Jackson1470
Jefferson1320
Yamhill1328
Klamath1301
Benton935
Morrow931
Hood River880
Wasco881
Josephine521
Clatsop510
Douglas460
Coos420
Columbia360
Lake210
Tillamook140
Crook120
Wallowa100
Curry80
Baker50
Sherman20
Gilliam10
Grant10
Harney10
Unassigned00
Wheeler00

California Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 252895

Reported Deaths: 6334
CountyConfirmedDeaths
Los Angeles1078263457
Riverside19450479
Orange16191363
San Diego15696387
San Bernardino13676269
Imperial7039114
Alameda6556140
Fresno585177
Kern513081
Santa Clara5077160
Tulare4627136
San Joaquin447455
Sacramento400469
San Francisco377650
Contra Costa356481
San Mateo3536108
Santa Barbara326129
Ventura324047
Marin271921
Kings260032
Stanislaus253144
Monterey191515
Solano147625
Sonoma135911
Merced127211
Placer82811
San Luis Obispo7012
Yolo61325
Madera5785
Santa Cruz4553
Napa3764
San Benito2652
Sutter2433
Lassen2420
El Dorado2260
Butte2063
Shasta1484
Humboldt1444
Nevada1291
Glenn1220
Yuba1061
Tehama881
Lake870
Mendocino850
Colusa700
Del Norte581
Calaveras530
Mono451
Tuolumne430
Inyo331
Amador310
Siskiyou310
Mariposa271
Plumas110
Alpine20
Trinity20
Sierra10
Unassigned00
Medford
Clear
77° wxIcon
Hi: 86° Lo: 53°
Feels Like: 78°
Brookings
Clear
57° wxIcon
Hi: 63° Lo: 47°
Feels Like: 57°
Crater Lake
Clear
74° wxIcon
Hi: 77° Lo: 45°
Feels Like: 74°
Grants Pass
Clear
77° wxIcon
Hi: 86° Lo: 52°
Feels Like: 78°
Klamath Falls
Clear
74° wxIcon
Hi: 81° Lo: 42°
Feels Like: 74°
Sunny weather continues Sunday
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events